Follow-Up Study of Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against All-Type and Serotype-Specific Invasive Pneumococcal Disease, Denmark

被引：1

作者：

Nielsen, Katrine Finderup ^{[1
,4
]}

Nielsen, Lise Birk ^{[1
]}

Dalby, Tine ^{[1
]}

Lomholt, Frederikke Kristensen ^{[1
]}

Slotved, Hans-Christian ^{[1
]}

Fuursted, Kurt ^{[1
]}

Harboe, Zitta Barrella ^{[1
,2
,3
]}

Jorgensen, Charlotte Svaerke ^{[1
]}

Valentiner-Branth, Palle ^{[1
]}

机构：

[1] Statens Serum Inst, Artillerivej 5, DK-2300 Copenhagen S, Denmark

[2] Copenhagen Univ Hosp, Copenhagen, Denmark

[3] Univ Copenhagen, Copenhagen, Denmark

[4] Statens Serum Inst, Artillerivej 5, DK-2300 Copenhagen, Denmark

来源：

EMERGING INFECTIOUS DISEASES | 2024年 / 30卷 / 06期

关键词：

AGED; 65; ENGLAND; PNEUMONIA; PEOPLE; ADULTS; IMPACT; OLDER;

D O I：

10.3201/eid3006.230975

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

As a follow-up to a previous study, we investigated vaccine effectiveness (VE) of 23-valent pneumococcal polysaccharide vaccine (PPSV23) against invasive pneumococcal disease (IPD) among 1,254,498 persons >= 65 years of age as part of a vaccination program in Denmark during Cox regression model and adjusted for age, sex, and underlying conditions. Using nationwide data, we estimated a VE of PPSV23 against all-type IPD of 32% and against PPSV23-serotype IPD of 41%. Because this follow-up study had more statistical power than the original study, we also estimated VE against IPD caused by PPSV23serotypes excluding serotype 3; serotype 3; serotype 8; serotype 22F; PPSV23 non-PCV15 serotypes; PPSV23 years of age against IPD caused by all serotypes or serotype groupings, except serotype 3.

引用

页码：1164 / 1172

页数：9

共 43 条

[21]

Krause TG, 2012, EUROSURVEILLANCE, V17, P5

[22] Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against vaccine serotype pneumococcal pneumonia in adults: A case-control test-negative design study [J].

Lawrence, Hannah ;

Pick, Harry ;

Baskaran, Vadsala ;

Daniel, Priya ;

Rodrigo, Chamira ;

Ashton, Deborah ;

Edwards-Pritchard, Rochelle C. ;

Sheppard, Carmen ;

Eletu, Seyi D. ;

Litt, David ;

Fry, Norman K. ;

Rose, Samuel ;

Trotter, Caroline ;

McKeever, Tricia M. ;

Lim, Wei Shen .

PLOS MEDICINE, 2020, 17 (10)

[23] Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against Invasive Disease and Hospital-Treated Pneumonia Among People Aged ≥65 Years: A Retrospective Case-Control Study [J].

Leventer-Roberts, Maya ;

Feldman, Becca S. ;

Brufman, Ilan ;

Cohen-Stavi, Chandra J. ;

Hoshen, Moshe ;

Balicer, Ran D. .

CLINICAL INFECTIOUS DISEASES, 2015, 60 (10) :1472-1480

[24] Persistence of immunity to conjugate and polysaccharide pneumococcal vaccines in frail, hospitalised older adults in long-term follow up [J].

MacIntyre, C. Raina ;

Ridda, Iman ;

Trent, Mallory J. ;

McIntyre, Peter .

VACCINE, 2019, 37 (35) :5016-5024

[25] Effectiveness of the 23-valent pneumococcal polysaccharide vaccine against invasive pneumococcal disease among 948,263 individuals ≥ 65 years of age: a Danish cohort study [J].

Nielsen, Katrine Finderup ;

Nielsen, Lise Birk ;

Lomholt, Frederikke Kristensen ;

Norgaard, Sarah Kristine ;

Slotved, Hans-Christian ;

Dalby, Tine ;

Fuursted, Kurt ;

Jorgensen, Charlotte Svaerke ;

Valentiner-Branth, Palle .

EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2022, 41 (12) :1473-1477

[26]

Norwegian Institute of Public Health, Recommendations for the use of pneumococcal vaccine outside the child vaccination program in Norway

[27] Pneumococcal vaccine uptake and vaccine effectiveness in older adults with invasive pneumococcal disease in Germany: A retrospective cohort study [J].

Perniciaro, Stephanie ;

van der Linden, Mark .

LANCET REGIONAL HEALTH-EUROPE, 2021, 7

[28] The Danish health care system and epidemiological research: from health care contacts to database records [J].

Schmidt, Morten ;

Schmidt, Sigrun Alba Johannesdottir ;

Adelborg, Kasper ;

Sundboll, Jens ;

Laugesen, Kristina ;

Ehrenstein, Vera ;

Sorensen, Henrik Toft .

CLINICAL EPIDEMIOLOGY, 2019, 11 :563-591

[29] THE PROTECTIVE EFFICACY OF POLYVALENT PNEUMOCOCCAL POLYSACCHARIDE VACCINE [J].

SHAPIRO, ED ;

BERG, AT ;

AUSTRIAN, R ;

SCHROEDER, D ;

PARCELLS, V ;

MARGOLIS, A ;

ADAIR, RK ;

CLEMENS, JD .

NEW ENGLAND JOURNAL OF MEDICINE, 1991, 325 (21) :1453-1460

[30] Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine against Invasive Pneumococcal Disease in Adults, Japan, 2013-2017 [J].

Shimbashi, Reiko ;

Suzuki, Motoi ;

Chang, Bin ;

Watanabe, Hiroshi ;

Tanabe, Yoshinari ;

Kuronuma, Koji ;

Oshima, Kengo ;

Maruyama, Takaya ;

Takeda, Hiroaki ;

Kasahara, Kei ;

Fujita, Jiro ;

Nishi, Junichiro ;

Kubota, Tetsuya ;

Tanaka-Taya, Keiko ;

Matsui, Tamano ;

Sunagawa, Tomimasa ;

Oishi, Kazunori .

EMERGING INFECTIOUS DISEASES, 2020, 26 (10) :2378-2386

← 1 2 3 4 5 →